首页 > 最新文献

Cancer Epidemiology, Biomarkers & Prevention最新文献

英文 中文
Selected Articles from This Issue 本期精选文章
Pub Date : 2023-11-01 DOI: 10.1158/1055-9965.epi-32-11-hi
Highlights| November 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (11): 1475. https://doi.org/10.1158/1055-9965.EPI-32-11-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record November 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 November 2023; 32 (11): 1475. https://doi.org/10.1158/1055-9965.EPI-32-11-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search This study by Forjaz and colleagues is the first comprehensive analysis of long-term incidence and survival trends for several cancer sites by stage. The authors created a new variable, Long-Term Site-Specific Summary Stage, and applied it to 25 cancer sites to allow analyses of long-term cancer incidence and survival trends by stage from as early as 1975. They report remarkable improvements in cancer survival since 1975, namely for cancers that have traditionally had a poor prognosis and no organized screening programs, which likely reflect advances in managing and treating these cancers. This study will be particularly useful for understanding the population-level impact of new treatments and identifying emerging trends in health disparities research. Risk prediction models may improve effective and efficient use of supplemental surveillance imaging for individuals with a personal history of breast cancer. However, using risk models to guide supplemental imaging recommendations may contribute to disparities. Using simulation... You do not currently have access to this content.
亮点| 2023年11月1日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(11): 1475。https://doi.org/10.1158/1055-9965.EPI-32-11-HI查看图标查看文章内容图表和表格视频音频补充数据同行评审共享图标共享Facebook Twitter LinkedIn电子邮件工具图标工具获得权限引用图标引用搜索网站文章版本图标版本记录版本2023年11月1日引用本问题选定的文章。2023年11月1日;32(11): 1475。https://doi.org/10.1158/1055-9965.EPI-32-11-HI下载引文文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索这项由Forjaz及其同事进行的研究首次全面分析了几种癌症部位分期的长期发病率和生存趋势。作者创造了一个新的变量,长期部位特异性总结阶段,并将其应用于25个癌症部位,以便从1975年开始分析长期癌症发病率和分期生存趋势。他们报告说,自1975年以来,癌症存活率有了显著提高,特别是对于那些传统上预后不佳、没有组织筛查项目的癌症,这可能反映了管理和治疗这些癌症的进步。这项研究将特别有助于了解新疗法对人口水平的影响,并确定健康差异研究中的新趋势。对于有乳腺癌病史的个体,风险预测模型可以提高辅助监测成像的有效性和效率。然而,使用风险模型来指导补充成像建议可能会导致差异。使用模拟……您目前没有访问此内容的权限。
{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-11-hi","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-32-11-hi","url":null,"abstract":"Highlights| November 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (11): 1475. https://doi.org/10.1158/1055-9965.EPI-32-11-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record November 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 November 2023; 32 (11): 1475. https://doi.org/10.1158/1055-9965.EPI-32-11-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search This study by Forjaz and colleagues is the first comprehensive analysis of long-term incidence and survival trends for several cancer sites by stage. The authors created a new variable, Long-Term Site-Specific Summary Stage, and applied it to 25 cancer sites to allow analyses of long-term cancer incidence and survival trends by stage from as early as 1975. They report remarkable improvements in cancer survival since 1975, namely for cancers that have traditionally had a poor prognosis and no organized screening programs, which likely reflect advances in managing and treating these cancers. This study will be particularly useful for understanding the population-level impact of new treatments and identifying emerging trends in health disparities research. Risk prediction models may improve effective and efficient use of supplemental surveillance imaging for individuals with a personal history of breast cancer. However, using risk models to guide supplemental imaging recommendations may contribute to disparities. Using simulation... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"285 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135273643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Articles from This Issue 本期精选文章
Pub Date : 2023-10-02 DOI: 10.1158/1055-9965.epi-32-10-hi
Highlights| October 02 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (10): 1273. https://doi.org/10.1158/1055-9965.EPI-32-10-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record October 2 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 October 2023; 32 (10): 1273. https://doi.org/10.1158/1055-9965.EPI-32-10-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Although esophageal cancer mortality is high in China, evidence suggests that mortality varies considerably by region. Using nationwide survey and cancer registry data from 782 counties in China, Ran and colleagues examined how geographic disparities in esophageal cancer mortality changed over time and investigated possible associations with socioeconomic status. Between 1973–1975 and 2015–2017, 577 (74%) counties experienced decreasing esophageal cancer mortality. Intercounty differences in mortality substantially narrowed, but geographic clusters of elevated rates persisted. Notably, elevated mortality rates were observed in counties with low socioeconomic status. These findings highlight the importance of continued efforts to address geographic and socioeconomic inequalities. Inequalities in high-quality breast cancer treatment are well established, however, the diagnostic procedures and clinical workups necessary to determine the optimal course of cancer-directed treatment are rarely considered. Herbach and colleagues provide a detailed depiction of disparities along the breast cancer continuum of care using SEER-Medicare data to examine racial–ethnic... You do not currently have access to this content.
亮点| 2023年10月2日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(10): 1273。https://doi.org/10.1158/1055-9965.EPI-32-10-HI查看图标查看文章内容图表和表格视频音频补充数据同行评审共享图标共享Facebook Twitter LinkedIn电子邮件工具图标工具获得权限引用图标引用搜索网站文章版本图标版本记录版本2023年10月2日引用本问题选定的文章。2023年10月1日;32(10): 1273。https://doi.org/10.1158/1055-9965.EPI-32-10-HI下载引文文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索虽然食管癌死亡率在中国很高,但有证据表明死亡率在不同地区差异很大。利用中国782个县的全国调查和癌症登记数据,Ran及其同事研究了食管癌死亡率的地理差异如何随着时间的推移而变化,并调查了与社会经济地位的可能关联。在1973-1975年和2015-2017年期间,577个县(74%)的食管癌死亡率下降。县与县之间的死亡率差异大大缩小,但高死亡率的地理聚集性持续存在。值得注意的是,在社会经济地位较低的县,死亡率较高。这些发现强调了继续努力解决地理和社会经济不平等问题的重要性。高质量乳腺癌治疗的不平等是众所周知的,然而,确定癌症导向治疗的最佳过程所必需的诊断程序和临床检查很少被考虑。Herbach和他的同事们使用SEER-Medicare数据对乳腺癌连续治疗的差异进行了详细的描述,以检查种族-民族…您目前没有访问此内容的权限。
{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-10-hi","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-32-10-hi","url":null,"abstract":"Highlights| October 02 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (10): 1273. https://doi.org/10.1158/1055-9965.EPI-32-10-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record October 2 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 October 2023; 32 (10): 1273. https://doi.org/10.1158/1055-9965.EPI-32-10-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Although esophageal cancer mortality is high in China, evidence suggests that mortality varies considerably by region. Using nationwide survey and cancer registry data from 782 counties in China, Ran and colleagues examined how geographic disparities in esophageal cancer mortality changed over time and investigated possible associations with socioeconomic status. Between 1973–1975 and 2015–2017, 577 (74%) counties experienced decreasing esophageal cancer mortality. Intercounty differences in mortality substantially narrowed, but geographic clusters of elevated rates persisted. Notably, elevated mortality rates were observed in counties with low socioeconomic status. These findings highlight the importance of continued efforts to address geographic and socioeconomic inequalities. Inequalities in high-quality breast cancer treatment are well established, however, the diagnostic procedures and clinical workups necessary to determine the optimal course of cancer-directed treatment are rarely considered. Herbach and colleagues provide a detailed depiction of disparities along the breast cancer continuum of care using SEER-Medicare data to examine racial–ethnic... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135835434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Articles from This Issue 本期精选文章
Pub Date : 2023-09-01 DOI: 10.1158/1055-9965.epi-32-9-hi
Highlights| September 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (9): 1125. https://doi.org/10.1158/1055-9965.EPI-32-9-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record September 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 September 2023; 32 (9): 1125. https://doi.org/10.1158/1055-9965.EPI-32-9-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search The risk for colorectal cancer and colon polyps, the precursors to colorectal cancer, varies between people for largely unclear reasons, one of which is field cancerization. The evidence for field cancerization in the colon has been modest to date. In this study, Yu and colleagues carried out studies using methylated EVL as a marker for field cancerization in the colon and a possible risk biomarker for colon polyps. The authors found mEVL associated with a 3X increased risk for colon polyps. Results provide more support for colon field cancerization and suggest mEVL may be a novel risk marker for colorectal cancer and therapeutic target for colorectal cancer chemoprevention. Human papillomavirus (HPV) cell entry through host cell surface receptors could correlate with infectivity and may play a role in cervical precancer progression. It has been shown that heparan sulfate proteoglycans (HSPG), specifically the syndecan and glypican gene families are... You do not currently have access to this content.
亮点| 2023年9月1日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(9): 1125。https://doi.org/10.1158/1055-9965.EPI-32-9-HI查看图标查看文章内容图表和表格视频音频补充数据同行评审共享图标共享Facebook Twitter LinkedIn电子邮件工具图标工具获得权限引用图标引用搜索网站文章版本图标版本记录版本2023年9月1日引用本问题选定的文章。癌症流行病学生物标志物20123年9月1日;32(9): 1125。https://doi.org/10.1158/1055-9965.EPI-32-9-HI下载引文文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索结直肠癌和结肠息肉(结直肠癌的前兆)的风险在很大程度上因不明原因而有所不同,其中之一是领域癌变。到目前为止,结肠野地癌变的证据还不多。在这项研究中,Yu及其同事将甲基化EVL作为结肠肿瘤的标志物和结肠息肉的可能风险生物标志物进行了研究。作者发现,mEVL与结肠息肉风险增加3倍有关。结果为结直肠野区癌变提供了更多的支持,提示mEVL可能是结直肠癌新的危险标志物和结直肠癌化学预防的治疗靶点。人乳头瘤病毒(HPV)通过宿主细胞表面受体进入细胞可能与感染性相关,并可能在宫颈癌前期进展中发挥作用。研究表明,硫酸肝素蛋白聚糖(HSPG),特别是syndecan和glypican基因家族是一种有效的基因。您目前没有访问此内容的权限。
{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-9-hi","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-32-9-hi","url":null,"abstract":"Highlights| September 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (9): 1125. https://doi.org/10.1158/1055-9965.EPI-32-9-HI Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record September 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 September 2023; 32 (9): 1125. https://doi.org/10.1158/1055-9965.EPI-32-9-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search The risk for colorectal cancer and colon polyps, the precursors to colorectal cancer, varies between people for largely unclear reasons, one of which is field cancerization. The evidence for field cancerization in the colon has been modest to date. In this study, Yu and colleagues carried out studies using methylated EVL as a marker for field cancerization in the colon and a possible risk biomarker for colon polyps. The authors found mEVL associated with a 3X increased risk for colon polyps. Results provide more support for colon field cancerization and suggest mEVL may be a novel risk marker for colorectal cancer and therapeutic target for colorectal cancer chemoprevention. Human papillomavirus (HPV) cell entry through host cell surface receptors could correlate with infectivity and may play a role in cervical precancer progression. It has been shown that heparan sulfate proteoglycans (HSPG), specifically the syndecan and glypican gene families are... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135048897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Articles from This Issue 本期精选文章
Pub Date : 2023-08-01 DOI: 10.1158/1055-9965.epi-32-8-hi
Highlights| August 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (8): 995. https://doi.org/10.1158/1055-9965.EPI-32-8-HI Related Content This is a commentary to: Prediagnostic 25-Hydroxyvitamin D in Association with Cancer-specific and All-cause Mortality among Low-income, Non-Hispanic Black Americans with Colorectal Cancer This is a commentary to: Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012–2016 This is a commentary to: Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium View more This is a commentary to: Field Synopsis of Environmental and Genetic Risk Factors of Sporadic Early-Onset Colorectal Cancer and Advanced Adenoma View less Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record August 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 August 2023; 32 (8): 995. https://doi.org/10.1158/1055-9965.EPI-32-8-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Acute lymphoblastic leukemia (ALL) accounts for 80% of all leukemias diagnosed in children. Although ALL age patterns are consistent across racial/ethnic groups, their incidence and mortality rates are highly variable. Montes-Rodríguez and colleagues assessed the age-standardized ALL incidence and mortality rates of Puerto Rican Hispanic (PRH) children and compared them with those of US mainland Hispanics, non-Hispanic whites, non-Hispanic blacks and Non-Hispanic Asian or Pacific Islanders. PRH children were found to have disparities in ALL incidence and mortality rates compared to other racial/ethnic groups in the US. Additional research is warranted to identify the genetic and environmental risk factors that may be associated with the disparities observed. This study by Zhang and colleagues synthesized available epidemiological evidence on the associations of environmental and genetic factors with the risk of sporadic early-onset colorectal cancer (EOCRC) and early-onset advanced colorectal adenoma (EOCRA). A total of 61 studies were included, reporting 120 environmental... You do not currently have access to this content.
亮点| 2023年8月1日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(8): 995。https://doi.org/10.1158/1055-9965.EPI-32-8-HI相关内容这是对以下内容的评论:25-羟基维生素D与低收入、非西班牙裔美国黑人结直肠癌患者癌症特异性和全因死亡率相关的预诊断。这是对2012-2016年波多黎各西班牙裔儿童急性淋巴细胞白血病发病率和死亡率的评论。这是对子宫内膜异位症妇女叶酸摄入量和卵巢癌风险的评论:一项来自卵巢癌协会联合会的病例对照研究查看更多这是一篇关于:散发性早发性结直肠癌和晚期腺瘤的环境和遗传风险因素现场概述查看少查看图标查看文章内容图&表视频音频补充数据同行评审共享图标共享Facebook Twitter LinkedIn电子邮件工具图标工具获得许可引用图标引用搜索网站文章版本图标版本记录版本2023年8月1日引用本期文章精选。癌症流行病学生物标志物20123年8月1日;32(8): 995。https://doi.org/10.1158/1055-9965.EPI-32-8-HI下载引用文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索急性淋巴细胞白血病(ALL)占所有儿童白血病诊断的80%。虽然所有的年龄模式在种族/族裔群体中是一致的,但它们的发病率和死亡率变化很大。Montes-Rodríguez及其同事评估了波多黎各西班牙裔儿童的年龄标准化ALL发病率和死亡率,并将其与美国大陆西班牙裔、非西班牙裔白人、非西班牙裔黑人、非西班牙裔亚裔或太平洋岛民的发病率和死亡率进行了比较。与美国其他种族/族裔相比,公屋儿童在ALL发病率和死亡率方面存在差异。有必要进行进一步的研究,以确定可能与所观察到的差异有关的遗传和环境风险因素。Zhang及其同事的这项研究综合了环境和遗传因素与散发性早发性结直肠癌(EOCRC)和早发性晚期结直肠腺瘤(EOCRA)风险的关联的现有流行病学证据。共纳入61项研究,报告了120个环境…您目前没有访问此内容的权限。
{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-8-hi","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-32-8-hi","url":null,"abstract":"Highlights| August 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (8): 995. https://doi.org/10.1158/1055-9965.EPI-32-8-HI Related Content This is a commentary to: Prediagnostic 25-Hydroxyvitamin D in Association with Cancer-specific and All-cause Mortality among Low-income, Non-Hispanic Black Americans with Colorectal Cancer This is a commentary to: Incidence and Mortality Rates for Childhood Acute Lymphoblastic Leukemia in Puerto Rican Hispanics, 2012–2016 This is a commentary to: Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium View more This is a commentary to: Field Synopsis of Environmental and Genetic Risk Factors of Sporadic Early-Onset Colorectal Cancer and Advanced Adenoma View less Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record August 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 August 2023; 32 (8): 995. https://doi.org/10.1158/1055-9965.EPI-32-8-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Acute lymphoblastic leukemia (ALL) accounts for 80% of all leukemias diagnosed in children. Although ALL age patterns are consistent across racial/ethnic groups, their incidence and mortality rates are highly variable. Montes-Rodríguez and colleagues assessed the age-standardized ALL incidence and mortality rates of Puerto Rican Hispanic (PRH) children and compared them with those of US mainland Hispanics, non-Hispanic whites, non-Hispanic blacks and Non-Hispanic Asian or Pacific Islanders. PRH children were found to have disparities in ALL incidence and mortality rates compared to other racial/ethnic groups in the US. Additional research is warranted to identify the genetic and environmental risk factors that may be associated with the disparities observed. This study by Zhang and colleagues synthesized available epidemiological evidence on the associations of environmental and genetic factors with the risk of sporadic early-onset colorectal cancer (EOCRC) and early-onset advanced colorectal adenoma (EOCRA). A total of 61 studies were included, reporting 120 environmental... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"34 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135970598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract 40: Global Cancer Surgery in Low-Resource Settings: A Strengths, Weaknesses, Opportunities, and Threats Analysis 摘要40:低资源环境下的全球癌症手术:优势、劣势、机会和威胁分析
Pub Date : 2023-06-01 DOI: 10.1158/1538-7755.asgcr23-abstract-40
Samantha Sadler, Erick Torio, Alexandra Golby
Abstract Background: Cancer surgery is a resource-intensive yet essential component of cancer care. In the face of projected increase in cancer burden, the present gap in cancer surgery care in low-resource settings with stressed healthcare and surgical infrastructure risks further exacerbation. Understanding the current state of global cancer surgery is essential to determining the best way forward. Purpose: The objectives of this report are to (1) describe the landscape of global cancer surgery literature and (2) characterize these findings through a Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis. Methods: A literature review was performed of global cancer surgery studies involving low-resource settings published since the landmark 2015 Lancet Commission on Global Surgery and Global Cancer Surgery. Studies were summarized and evaluated for themes, which were further grouped into SWOT categories for analysis. Results: The online literature search yielded 123 articles, of which 46 articles met inclusion criteria for analysis. The majority of included studies were open access (n=34) and published between 2021 and 2022 (n=26). Conclusion: The body of published global cancer surgery literature is growing, perhaps reflecting increased research attention and valuation. From the reviewed literature, Strengths of the global cancer surgery field include a body of studies investigating important aspects of cancer surgery in low-resource settings: local cancer epidemiology, local surgical and technological innovation, quality-of-life as a key surgical outcome metric, and advancements in cancer surgery through interdisciplinary work. Weaknesses include systems-level limitations (i.e. resources, perioperative services, broader health system gaps) and a paucity of detailed economic analyses. Opportunities include diverse local cancer management strategies, successful inter-setting collaborations supporting research, education, and surgical skills training, and thoughtful research expansion for an inclusive future. Threats include large-scale stresses on local healthcare infrastructure (i.e. COVID-19) and the risk of widening disparities posed by unchecked technological. Conclusion: This SWOT analysis may inform local intervention strategies and action plans to help LMIC stakeholders achieve cancer surgery goals. Similar analyses are needed locally to help elucidate best practices that might be applied or tailored to similar settings globally. Citation Format: Samantha Sadler, Erick Torio, Alexandra Golby. Global Cancer Surgery in Low-Resource Settings: A Strengths, Weaknesses, Opportunities, and Threats Analysis [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 40.
背景:肿瘤手术是癌症治疗中资源密集型的重要组成部分。面对预计的癌症负担的增加,目前在低资源环境中,在医疗保健和手术基础设施紧张的情况下,癌症手术护理的差距有进一步加剧的风险。了解全球癌症手术的现状对于确定最佳的前进道路至关重要。目的:本报告的目的是(1)描述全球癌症手术文献的概况,(2)通过优势、劣势、机会和威胁(SWOT)分析来描述这些发现。方法:对具有里程碑意义的2015年柳叶刀全球外科和全球癌症外科委员会以来发表的涉及低资源环境的全球癌症外科研究进行文献综述。对研究主题进行总结和评估,并进一步分组为SWOT分类进行分析。结果:网络文献检索得到123篇,其中46篇符合纳入标准。大多数纳入的研究是开放获取的(n=34),发表于2021年至2022年之间(n=26)。结论:全球发表的癌症外科文献数量正在增长,这可能反映了研究的关注度和价值的提高。从文献综述来看,全球癌症手术领域的优势包括在低资源环境下研究癌症手术的重要方面:当地癌症流行病学,当地手术和技术创新,作为关键手术结果指标的生活质量,以及通过跨学科工作在癌症手术方面的进展。弱点包括系统层面的限制(即资源、围手术期服务、更广泛的卫生系统差距)和缺乏详细的经济分析。机会包括多样化的当地癌症管理策略,成功的跨环境合作支持研究、教育和手术技能培训,以及为包容性未来进行深思熟虑的研究扩展。威胁包括对当地医疗基础设施的大规模压力(即COVID-19)以及不受控制的技术造成的差距扩大的风险。结论:SWOT分析可以为当地的干预策略和行动计划提供信息,帮助LMIC利益相关者实现癌症手术目标。需要在当地进行类似的分析,以帮助阐明可能适用于或适合于全球类似环境的最佳做法。引文格式:Samantha Sadler, Erick Torio, Alexandra Golby。低资源环境下的全球癌症手术:优势、劣势、机会和威胁分析[摘要]。第11届全球癌症研究年会论文集;缩小从研究到实施的差距;2023年4月4-6日。费城(PA): AACR;癌症流行病学杂志[j]; 2009;32(6 -增刊):摘要[40]。
{"title":"Abstract 40: Global Cancer Surgery in Low-Resource Settings: A Strengths, Weaknesses, Opportunities, and Threats Analysis","authors":"Samantha Sadler, Erick Torio, Alexandra Golby","doi":"10.1158/1538-7755.asgcr23-abstract-40","DOIUrl":"https://doi.org/10.1158/1538-7755.asgcr23-abstract-40","url":null,"abstract":"Abstract Background: Cancer surgery is a resource-intensive yet essential component of cancer care. In the face of projected increase in cancer burden, the present gap in cancer surgery care in low-resource settings with stressed healthcare and surgical infrastructure risks further exacerbation. Understanding the current state of global cancer surgery is essential to determining the best way forward. Purpose: The objectives of this report are to (1) describe the landscape of global cancer surgery literature and (2) characterize these findings through a Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis. Methods: A literature review was performed of global cancer surgery studies involving low-resource settings published since the landmark 2015 Lancet Commission on Global Surgery and Global Cancer Surgery. Studies were summarized and evaluated for themes, which were further grouped into SWOT categories for analysis. Results: The online literature search yielded 123 articles, of which 46 articles met inclusion criteria for analysis. The majority of included studies were open access (n=34) and published between 2021 and 2022 (n=26). Conclusion: The body of published global cancer surgery literature is growing, perhaps reflecting increased research attention and valuation. From the reviewed literature, Strengths of the global cancer surgery field include a body of studies investigating important aspects of cancer surgery in low-resource settings: local cancer epidemiology, local surgical and technological innovation, quality-of-life as a key surgical outcome metric, and advancements in cancer surgery through interdisciplinary work. Weaknesses include systems-level limitations (i.e. resources, perioperative services, broader health system gaps) and a paucity of detailed economic analyses. Opportunities include diverse local cancer management strategies, successful inter-setting collaborations supporting research, education, and surgical skills training, and thoughtful research expansion for an inclusive future. Threats include large-scale stresses on local healthcare infrastructure (i.e. COVID-19) and the risk of widening disparities posed by unchecked technological. Conclusion: This SWOT analysis may inform local intervention strategies and action plans to help LMIC stakeholders achieve cancer surgery goals. Similar analyses are needed locally to help elucidate best practices that might be applied or tailored to similar settings globally. Citation Format: Samantha Sadler, Erick Torio, Alexandra Golby. Global Cancer Surgery in Low-Resource Settings: A Strengths, Weaknesses, Opportunities, and Threats Analysis [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 40.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135727421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Selected Articles from This Issue 本期精选文章
Pub Date : 2023-06-01 DOI: 10.1158/1055-9965.epi-32-6-hi
Highlights| June 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (6): 739. https://doi.org/10.1158/1055-9965.EPI-32-6-HI Related Content A commentary has been published: Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study A commentary has been published: Efficacy of the Outsmart HPV Intervention: A Randomized Controlled Trial to Increase HPV Vaccination among Young Gay, Bisexual, and Other Men Who Have Sex with Men A commentary has been published: Survival of Middle Eastern and North African Individuals Diagnosed with Colorectal Cancer: A Population-Based Study in California View more A commentary has been published: Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors View less Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record June 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 June 2023; 32 (6): 739. https://doi.org/10.1158/1055-9965.EPI-32-6-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Routine human papillomavirus (HPV) vaccination is recommended for young adults, yet many young gay, bisexual, and other men who have sex with men (YGBMSM) remain unvaccinated. Reiter and colleagues report the efficacy of Outsmart HPV, a web-based HPV vaccination intervention for YGBMSM. Results showed that Outsmart HPV increased HPV vaccination among participants and that participants reported higher levels of satisfaction with the intervention. These data suggest that Outsmart HPV is an efficacious intervention and a promising tool for increasing HPV vaccination among YGBMSM. Cardiovascular disease is a major cause of illness and death in cancer patients. Sun and colleagues analyzed data from the UK Biobank to investigate the link between mosaic chromosomal alterations (mCAs), a type of clonal hematopoiesis, and cardiovascular outcomes in cancer patients. The authors found that patients with mCAs had a significantly higher risk of death from coronary artery disease compared to those without mCAs. These findings... You do not currently have access to this content.
亮点| 2023年6月1日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(6): 739。https://doi.org/10.1158/1055-9965.EPI-32-6-HI相关内容一篇评论已经发表:2006-2030年中国宫颈癌发病率和死亡率趋势:贝叶斯年龄-时期-队列模型研究一篇评论已经发表:Outsmart HPV干预的有效性:一项增加年轻男同性恋、双性恋和其他男男性行为者接种HPV疫苗的随机对照试验一篇评论已经发表:中东和北非结直肠癌患者的生存率:加州一项基于人群的研究癌症幸存者的体细胞马赛克染色体改变和心血管疾病死亡原因查看较少查看图标查看文章内容图表和表格视频音频补充数据同行评审分享图标分享Facebook Twitter LinkedIn电子邮件工具图标工具获得许可引用图标引用搜索网站文章版本图标版本记录版本2023年6月1日引用本期精选文章。癌症流行病学生物标志物20123年6月1日;32(6): 739。https://doi.org/10.1158/1055-9965.EPI-32-6-HI下载引用文件:Ris (Zotero)参考文献管理器EasyBib Bookends Mendeley论文EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索推荐年轻人常规接种人乳头瘤病毒(HPV)疫苗,但许多年轻的同性恋,双性恋和其他男同性恋者(YGBMSM)仍然未接种疫苗。Reiter及其同事报告了Outsmart HPV的有效性,这是一种基于网络的针对YGBMSM的HPV疫苗接种干预。结果显示,Outsmart HPV增加了参与者的HPV疫苗接种,参与者对干预的满意度更高。这些数据表明,Outsmart HPV是一种有效的干预措施,也是增加YGBMSM中HPV疫苗接种的有希望的工具。心血管疾病是癌症患者患病和死亡的主要原因。Sun和他的同事们分析了来自英国生物银行的数据,以调查马赛克染色体改变(mCAs),一种克隆造血和癌症患者心血管预后之间的联系。作者发现,与没有mca的患者相比,mca患者死于冠状动脉疾病的风险明显更高。这些发现……您目前没有访问此内容的权限。
{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-6-hi","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-32-6-hi","url":null,"abstract":"Highlights| June 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (6): 739. https://doi.org/10.1158/1055-9965.EPI-32-6-HI Related Content A commentary has been published: Trend in Cervical Cancer Incidence and Mortality Rates in China, 2006–2030: A Bayesian Age-Period-Cohort Modeling Study A commentary has been published: Efficacy of the Outsmart HPV Intervention: A Randomized Controlled Trial to Increase HPV Vaccination among Young Gay, Bisexual, and Other Men Who Have Sex with Men A commentary has been published: Survival of Middle Eastern and North African Individuals Diagnosed with Colorectal Cancer: A Population-Based Study in California View more A commentary has been published: Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors View less Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record June 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 June 2023; 32 (6): 739. https://doi.org/10.1158/1055-9965.EPI-32-6-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Routine human papillomavirus (HPV) vaccination is recommended for young adults, yet many young gay, bisexual, and other men who have sex with men (YGBMSM) remain unvaccinated. Reiter and colleagues report the efficacy of Outsmart HPV, a web-based HPV vaccination intervention for YGBMSM. Results showed that Outsmart HPV increased HPV vaccination among participants and that participants reported higher levels of satisfaction with the intervention. These data suggest that Outsmart HPV is an efficacious intervention and a promising tool for increasing HPV vaccination among YGBMSM. Cardiovascular disease is a major cause of illness and death in cancer patients. Sun and colleagues analyzed data from the UK Biobank to investigate the link between mosaic chromosomal alterations (mCAs), a type of clonal hematopoiesis, and cardiovascular outcomes in cancer patients. The authors found that patients with mCAs had a significantly higher risk of death from coronary artery disease compared to those without mCAs. These findings... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135727240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract 58: Leaving Cancer Patients Behind for Greener Pastures: The Clinical Oncology Workforce in Nigeria 摘要58:离开癌症患者到更绿色的牧场:尼日利亚的临床肿瘤学工作人员
Pub Date : 2023-06-01 DOI: 10.1158/1538-7755.asgcr23-abstract-58
Runcie C.W. Chidebe, Tochukwu C. Orjikor, Onyinye Balogun, Adedayo Joseph, Samantha Toland, Alison Simons
Abstract Purpose: For a population of over 201 million, Nigeria has only 4 doctors per 10,000 patients and 16.1 nurses, midwives per 10,000 patients, and less than 100 clinical oncologists for over 100,000 cancer patients. While Nigeria has one of the worst disease burdens in the world and a workforce shortage; 9 in 10 Nigerian physicians are seeking opportunities to leave for the USA, UK, and Canada. To improve oncology care in Nigeria, it may be important to understand the push and pull factors contributing to the migration of the clinical oncology (CO) workforce. Mathew (2018), Vanderpuye, et al., (2019), Balogun, et al., (2017), and Adebayo, (2016) have done research on CO; however, their studies were vastly focused on the African continent and not country-specific nor focused on the CO workforce in Nigeria.The aim of this study is to explore the push and pull factors to stay or leave the clinical oncology workforce in Nigeria. Methods: Using a mixed-method research approach, 80 participants completed the questionnaire and 9 participants responded to semi-structured interviews. Multiple linear regression and Grounded theory were used for the data analysis. Results: The results show that CO workload and satisfaction were significantly related to turnover intention. The qualitative results showed that CO as a new area of specialization, mentorship, career growth, and attractiveness of radiation science are the pull factors. While, high CO workload, poor healthcare system, poor remuneration, corruption in the public sector, and a few other themes are push factors. Empathy for patients, patriotism and a sense of fulfillment unexpectedly emerged as retention factors in the study. Conclusion: Nigeria can improve patient treatment outcomes by the reduction of CO workload through the employment of more CO. More CO can be available for employment when they are attracted, and their training is optimized. Those employed can be retained by improving working conditions and introducing work benefits. Our recommendations are that health leaders should create more CO training and awareness of CO in Nigeria. Citation Format: Runcie C.W. Chidebe, Tochukwu C. Orjikor, Onyinye Balogun, Adedayo Joseph, Samantha Toland, Alison Simons. Leaving Cancer Patients Behind for Greener Pastures: The Clinical Oncology Workforce in Nigeria [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 58.
摘要目的:尼日利亚人口超过2.01亿,每1万名患者中只有4名医生,每1万名患者中只有16.1名护士和助产士,每10万多名癌症患者中只有不到100名临床肿瘤学家。尼日利亚是世界上疾病负担最严重的国家之一,而且劳动力短缺;十分之九的尼日利亚医生正在寻找机会前往美国、英国和加拿大。为了改善尼日利亚的肿瘤护理,了解促进临床肿瘤(CO)工作人员迁移的推动和拉动因素可能很重要。Mathew(2018)、Vanderpuye等人(2019)、Balogun等人(2017)、Adebayo等人(2016)对CO进行了研究;然而,他们的研究主要集中在非洲大陆,而不是针对具体国家,也不是针对尼日利亚的CO劳动力。本研究的目的是探讨推动和拉动因素,以留在或离开临床肿瘤工作人员在尼日利亚。方法:采用混合研究方法,对80名参与者进行问卷调查,对9名参与者进行半结构化访谈。采用多元线性回归和扎根理论进行数据分析。结果:CO工作量和满意度与离职意向显著相关。定性结果表明,CO作为一个新的专业领域,指导,职业发展和辐射科学的吸引力是拉动因素。然而,高CO工作量、糟糕的医疗系统、低薪酬、公共部门的腐败和其他一些主题是推动因素。在这项研究中,对病人的同情、爱国主义和成就感意外地成为挽留因素。结论:尼日利亚可以通过雇佣更多的CO来减少CO的工作量,从而改善患者的治疗效果。当吸引到更多的CO时,可以有更多的CO可供就业,并优化他们的培训。可以通过改善工作条件和引入工作福利来留住被雇用的人。我们的建议是,卫生领导人应在尼日利亚开展更多的一氧化碳培训,提高对一氧化碳的认识。引文格式:Runcie C.W. Chidebe, Tochukwu C. Orjikor, Onyinye Balogun, Adedayo Joseph, Samantha Toland, Alison Simons。把癌症患者留在更绿色的牧场:尼日利亚的临床肿瘤学工作人员[摘要]。第11届全球癌症研究年会论文集;缩小从研究到实施的差距;2023年4月4-6日。费城(PA): AACR;癌症流行病学杂志[j]; 2013;32(6 -增刊):摘要nr . 58。
{"title":"Abstract 58: Leaving Cancer Patients Behind for Greener Pastures: The Clinical Oncology Workforce in Nigeria","authors":"Runcie C.W. Chidebe, Tochukwu C. Orjikor, Onyinye Balogun, Adedayo Joseph, Samantha Toland, Alison Simons","doi":"10.1158/1538-7755.asgcr23-abstract-58","DOIUrl":"https://doi.org/10.1158/1538-7755.asgcr23-abstract-58","url":null,"abstract":"Abstract Purpose: For a population of over 201 million, Nigeria has only 4 doctors per 10,000 patients and 16.1 nurses, midwives per 10,000 patients, and less than 100 clinical oncologists for over 100,000 cancer patients. While Nigeria has one of the worst disease burdens in the world and a workforce shortage; 9 in 10 Nigerian physicians are seeking opportunities to leave for the USA, UK, and Canada. To improve oncology care in Nigeria, it may be important to understand the push and pull factors contributing to the migration of the clinical oncology (CO) workforce. Mathew (2018), Vanderpuye, et al., (2019), Balogun, et al., (2017), and Adebayo, (2016) have done research on CO; however, their studies were vastly focused on the African continent and not country-specific nor focused on the CO workforce in Nigeria.The aim of this study is to explore the push and pull factors to stay or leave the clinical oncology workforce in Nigeria. Methods: Using a mixed-method research approach, 80 participants completed the questionnaire and 9 participants responded to semi-structured interviews. Multiple linear regression and Grounded theory were used for the data analysis. Results: The results show that CO workload and satisfaction were significantly related to turnover intention. The qualitative results showed that CO as a new area of specialization, mentorship, career growth, and attractiveness of radiation science are the pull factors. While, high CO workload, poor healthcare system, poor remuneration, corruption in the public sector, and a few other themes are push factors. Empathy for patients, patriotism and a sense of fulfillment unexpectedly emerged as retention factors in the study. Conclusion: Nigeria can improve patient treatment outcomes by the reduction of CO workload through the employment of more CO. More CO can be available for employment when they are attracted, and their training is optimized. Those employed can be retained by improving working conditions and introducing work benefits. Our recommendations are that health leaders should create more CO training and awareness of CO in Nigeria. Citation Format: Runcie C.W. Chidebe, Tochukwu C. Orjikor, Onyinye Balogun, Adedayo Joseph, Samantha Toland, Alison Simons. Leaving Cancer Patients Behind for Greener Pastures: The Clinical Oncology Workforce in Nigeria [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 58.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135728373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract 36: Examining Policies and Guidelines to Improve the Cervical Cancer Prevention and Treatment Pathway for Patients and Health Providers in Tanzania: A Qualitative Study 摘要36:检查政策和指导方针,以改善坦桑尼亚患者和卫生服务提供者的宫颈癌预防和治疗途径:一项定性研究
Pub Date : 2023-06-01 DOI: 10.1158/1538-7755.asgcr23-abstract-36
Melinda Chelva, Sanchit Kaushal, Nicola West, Erica Erwin, Prisca Dominic Marandu, Safina Yuma, Donna Shelley, Karen Yeates
Abstract Purpose: Cervical cancer is the fourth most common cancer in women around the globe. It has been identified as the most common cancer in Tanzania, resulting in about 9772 new cases and 6695 deaths each year. Several research studies have identified the importance of adequate and timely policies and guidelines to optimize the cervical cancer prevention and treatment pathway in the nation. However, there is scant literature on the perspectives of all stakeholders (e.g., patients, key informants, healthcare providers, and non-healthcare providers). Our study aims to better understand the recommendations from important stakeholders to inform current and upcoming policies and guidelines, and overall, improve the cervical cancer screening and treatment cascade in rural Tanzania and other African countries. Methods: We leveraged a framework for conducting a health systems assessment to identify healthcare providers’ perspectives on effective cervical cancer screening, prevention and control in Tanzania. We adapted interview topic guides for cervical cancer screening using the health systems assessment framework conceptualized by Risso-Gill and colleagues designed initially for evaluating hypertension control. Study participants (71) were interviewed between 2014-2018. This included key stakeholders, patients, healthcare providers and non-healthcare providers. Results: Through the interviews and focus group discussions that were conducted, three major themes emerged: 1) policies and guidelines, 2) burden of disease in relation to policies, and 3) treatment and follow-up. Sub-themes relating to policies and guidelines included health policies, governmental influence, data collection, and revision of HPV vaccination guidelines. Sub-themes for burden of disease included the rise in overall cases of cervical cancer. Subthemes for treatment and follow-up included quality of care, dissatisfaction with care, and patient safety and well-being. Conclusion: It is evident that significant changes must be made to existing policies and guidelines to improve many aspects of the cervical cancer screening and treatment pathway, to benefit healthcare providers and patients alike in rural Tanzania. There is also a critical need to implement new initiatives and programs to increase uptake and allow for informed-decision making among women. Citation Format: Melinda Chelva, Sanchit Kaushal, Nicola West, Erica Erwin, Prisca Dominic Marandu, Safina Yuma, Donna Shelley, Karen Yeates. Examining Policies and Guidelines to Improve the Cervical Cancer Prevention and Treatment Pathway for Patients and Health Providers in Tanzania: A Qualitative Study [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 36.
目的:宫颈癌是全球第四大最常见的女性癌症。它已被确定为坦桑尼亚最常见的癌症,每年导致约9772例新病例和6695例死亡。一些研究已经确定了适当和及时的政策和指南对于优化国家宫颈癌预防和治疗途径的重要性。然而,关于所有利益相关者(例如,患者、关键举报人、医疗保健提供者和非医疗保健提供者)的观点的文献很少。我们的研究旨在更好地了解重要利益相关者的建议,为当前和即将出台的政策和指导方针提供信息,并总体上改善坦桑尼亚农村和其他非洲国家的宫颈癌筛查和治疗梯级。方法:我们利用框架进行卫生系统评估,以确定在坦桑尼亚有效的宫颈癌筛查,预防和控制医疗保健提供者的观点。我们采用Risso-Gill及其同事最初为评估高血压控制而设计的卫生系统评估框架,对宫颈癌筛查的访谈主题指南进行了改编。研究参与者(71人)在2014-2018年间接受了采访。这包括关键利益攸关方、患者、医疗保健提供者和非医疗保健提供者。结果:通过访谈和焦点小组讨论,出现了三个主要主题:1)政策和指南,2)与政策相关的疾病负担,3)治疗和随访。与政策和指南有关的次级主题包括卫生政策、政府影响、数据收集和修订HPV疫苗接种指南。疾病负担的分主题包括宫颈癌总病例的增加。治疗和随访的次要主题包括护理质量、对护理的不满以及患者的安全和健康。结论:显然,必须对现有政策和指导方针进行重大修改,以改善宫颈癌筛查和治疗途径的许多方面,使坦桑尼亚农村的医疗保健提供者和患者都受益。还迫切需要实施新的倡议和方案,以提高妇女的吸收能力,并允许妇女作出知情决策。引文格式:Melinda Chelva, Sanchit Kaushal, Nicola West, Erica Erwin, Prisca Dominic Marandu, Safina Yuma, Donna Shelley, Karen Yeates。审查政策和指导方针,以改善坦桑尼亚患者和保健提供者的宫颈癌预防和治疗途径:一项定性研究[摘要]。第11届全球癌症研究年会论文集;缩小从研究到实施的差距;2023年4月4-6日。费城(PA): AACR;癌症流行病学杂志[j]; 2013;32(6 -增刊):摘要第36期。
{"title":"Abstract 36: Examining Policies and Guidelines to Improve the Cervical Cancer Prevention and Treatment Pathway for Patients and Health Providers in Tanzania: A Qualitative Study","authors":"Melinda Chelva, Sanchit Kaushal, Nicola West, Erica Erwin, Prisca Dominic Marandu, Safina Yuma, Donna Shelley, Karen Yeates","doi":"10.1158/1538-7755.asgcr23-abstract-36","DOIUrl":"https://doi.org/10.1158/1538-7755.asgcr23-abstract-36","url":null,"abstract":"Abstract Purpose: Cervical cancer is the fourth most common cancer in women around the globe. It has been identified as the most common cancer in Tanzania, resulting in about 9772 new cases and 6695 deaths each year. Several research studies have identified the importance of adequate and timely policies and guidelines to optimize the cervical cancer prevention and treatment pathway in the nation. However, there is scant literature on the perspectives of all stakeholders (e.g., patients, key informants, healthcare providers, and non-healthcare providers). Our study aims to better understand the recommendations from important stakeholders to inform current and upcoming policies and guidelines, and overall, improve the cervical cancer screening and treatment cascade in rural Tanzania and other African countries. Methods: We leveraged a framework for conducting a health systems assessment to identify healthcare providers’ perspectives on effective cervical cancer screening, prevention and control in Tanzania. We adapted interview topic guides for cervical cancer screening using the health systems assessment framework conceptualized by Risso-Gill and colleagues designed initially for evaluating hypertension control. Study participants (71) were interviewed between 2014-2018. This included key stakeholders, patients, healthcare providers and non-healthcare providers. Results: Through the interviews and focus group discussions that were conducted, three major themes emerged: 1) policies and guidelines, 2) burden of disease in relation to policies, and 3) treatment and follow-up. Sub-themes relating to policies and guidelines included health policies, governmental influence, data collection, and revision of HPV vaccination guidelines. Sub-themes for burden of disease included the rise in overall cases of cervical cancer. Subthemes for treatment and follow-up included quality of care, dissatisfaction with care, and patient safety and well-being. Conclusion: It is evident that significant changes must be made to existing policies and guidelines to improve many aspects of the cervical cancer screening and treatment pathway, to benefit healthcare providers and patients alike in rural Tanzania. There is also a critical need to implement new initiatives and programs to increase uptake and allow for informed-decision making among women. Citation Format: Melinda Chelva, Sanchit Kaushal, Nicola West, Erica Erwin, Prisca Dominic Marandu, Safina Yuma, Donna Shelley, Karen Yeates. Examining Policies and Guidelines to Improve the Cervical Cancer Prevention and Treatment Pathway for Patients and Health Providers in Tanzania: A Qualitative Study [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(6_Suppl):Abstract nr 36.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135728171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract 39: Factors Associated With Receiving Results and Attending Colposcopy in Patients With Positive HPV Screens in Mexico City 摘要:墨西哥城HPV筛查阳性患者接受结果和参加阴道镜检查的相关因素
Pub Date : 2023-06-01 DOI: 10.1158/1538-7755.asgcr23-abstract-39
Leith León-Maldonado, Raul U. Hernández-Ramírez, Leticia Torres-Ibarra, Donna Spiegelman, Sangini S Sheth, Eduardo Lazcano-Ponce, José Damián Cadena-Fiscal, Jorge Salmerón
Abstract Purpose: Unlike in high-income countries, where cervical cancer (CC) screening programs have resulted in a dramatic decrease in incidence and mortality of this nearly fully preventable disease, in low- and middle-income countries, the impact of these programs has been limited. Poor follow-up to abnormal cancer screening tests lessens the benefit of CC screening. We sought to identify multilevel factors at the level of patient, provider, and healthcare system related to receipt of screening results and attendance to colposcopy among patients with positive screening results in a CC screening program in Mexico. Methods: We studied 1,351 patients who were scheduled for colposcopy after testing positive for high-risk human papillomavirus in two screening demonstration studies conducted in Mexico City’s Tlalpan District (2017-2018). Multilevel factors associated with receipt of screening results and with adherence to a colposcopy appointment were identified using multivariable logistic regression. Results: Participants had a median age of 40 years, 58% had less than high school education, and 74% had a Pap screening recently (i.e., in the last 5 years). Fifty-five percent of participants retrieved their screening results at the healthcare facility before being reminded to do so. Greater adherence to obtaining screening test results was associated with providing an email address as contact information (Odds Ratio 1.35 [95% Confidence Interval 1.03-1.77]), attending a facility with family medicine (1.54 [1.07-2.21]), and receiving care from experienced nurses (1.85 [1.30-2.70]). Fifty-seven percent of participants attended their first scheduled colposcopy appointment. Providing a phone number as contact information was linked to improved adherence to colposcopy (1.27 [1.01-1.59]), whereas longer travel time between the healthcare facility and the colposcopy clinic was associated with a decrease in colposcopy adherence (0.68 [0.49-0.94]). Having a Pap recently was positively associated with better compliance with both outcomes (1.36 [0.96-1.94] for receiving results; 1.59 [1.10-2.29] for colposcopy adherence). Conclusion: We identified multilevel factors associated with abnormal test follow-up in patients in Mexico City. Additional research is necessary to design and test components for a multilevel intervention to address these factors and enable successful implementation of the follow-up process for abnormal screens from screening to diagnosis and treatment. Citation Format: Leith León-Maldonado, Raul U. Hernández-Ramírez, Leticia Torres-Ibarra, Donna Spiegelman, Sangini S Sheth, Eduardo Lazcano-Ponce, José Damián Cadena-Fiscal, Jorge Salmerón. Factors Associated With Receiving Results and Attending Colposcopy in Patients With Positive HPV Screens in Mexico City [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol B
目的:与高收入国家不同,宫颈癌(CC)筛查项目导致这种几乎完全可以预防的疾病的发病率和死亡率急剧下降,而在低收入和中等收入国家,这些项目的影响有限。对异常癌症筛查试验的不良随访减少了CC筛查的益处。在墨西哥的一个CC筛查项目中,我们试图在患者、提供者和医疗保健系统层面确定与接受筛查结果和参加阴道镜检查有关的多水平因素。方法:我们研究了在墨西哥城Tlalpan区(2017-2018)进行的两项筛查示范研究中高危人乳头瘤病毒检测阳性后计划进行阴道镜检查的1,351例患者。使用多变量逻辑回归确定与接受筛查结果和遵守阴道镜检查预约相关的多水平因素。结果:参与者的中位年龄为40岁,58%的人受教育程度低于高中,74%的人最近(即最近5年内)做过子宫颈抹片检查。55%的参与者在被提醒之前在医疗机构取回了他们的筛查结果。提供电子邮件地址作为联系信息(优势比1.35[95%置信区间1.03-1.77])、在家庭医疗机构就诊(优势比1.54[1.07-2.21])和接受经验丰富的护士护理(优势比1.85[1.30-2.70])与获得筛查结果的更强依从性相关。57%的参与者参加了第一次阴道镜检查预约。提供电话号码作为联系信息与提高阴道镜检查依从性相关(1.27[1.01-1.59]),而从医疗机构到阴道镜检查诊所之间的较长旅行时间与阴道镜检查依从性降低相关(0.68[0.49-0.94])。近期接受Pap检查与两种结果更好的依从性呈正相关(1.36 [0.96-1.94]);1.59[1.10-2.29]为阴道镜依从性)。结论:我们确定了与墨西哥城患者异常测试随访相关的多水平因素。需要进一步的研究来设计和测试多层次干预措施的组成部分,以解决这些因素,并使异常筛查从筛查到诊断和治疗的后续过程能够成功实施。引文格式:Leith León-Maldonado, Raul U. Hernández-Ramírez, Leticia Torres-Ibarra, Donna Spiegelman, Sangini S Sheth, Eduardo Lazcano-Ponce, jos Damián Cadena-Fiscal, Jorge Salmerón。墨西哥城HPV筛查阳性患者接受结果和参加阴道镜检查相关因素[摘要]。第11届全球癌症研究年会论文集;缩小从研究到实施的差距;2023年4月4-6日。费城(PA): AACR;癌症流行病学杂志[j]; 2009;32(6 -增刊):摘要第39期。
{"title":"Abstract 39: Factors Associated With Receiving Results and Attending Colposcopy in Patients With Positive HPV Screens in Mexico City","authors":"Leith León-Maldonado, Raul U. Hernández-Ramírez, Leticia Torres-Ibarra, Donna Spiegelman, Sangini S Sheth, Eduardo Lazcano-Ponce, José Damián Cadena-Fiscal, Jorge Salmerón","doi":"10.1158/1538-7755.asgcr23-abstract-39","DOIUrl":"https://doi.org/10.1158/1538-7755.asgcr23-abstract-39","url":null,"abstract":"Abstract Purpose: Unlike in high-income countries, where cervical cancer (CC) screening programs have resulted in a dramatic decrease in incidence and mortality of this nearly fully preventable disease, in low- and middle-income countries, the impact of these programs has been limited. Poor follow-up to abnormal cancer screening tests lessens the benefit of CC screening. We sought to identify multilevel factors at the level of patient, provider, and healthcare system related to receipt of screening results and attendance to colposcopy among patients with positive screening results in a CC screening program in Mexico. Methods: We studied 1,351 patients who were scheduled for colposcopy after testing positive for high-risk human papillomavirus in two screening demonstration studies conducted in Mexico City’s Tlalpan District (2017-2018). Multilevel factors associated with receipt of screening results and with adherence to a colposcopy appointment were identified using multivariable logistic regression. Results: Participants had a median age of 40 years, 58% had less than high school education, and 74% had a Pap screening recently (i.e., in the last 5 years). Fifty-five percent of participants retrieved their screening results at the healthcare facility before being reminded to do so. Greater adherence to obtaining screening test results was associated with providing an email address as contact information (Odds Ratio 1.35 [95% Confidence Interval 1.03-1.77]), attending a facility with family medicine (1.54 [1.07-2.21]), and receiving care from experienced nurses (1.85 [1.30-2.70]). Fifty-seven percent of participants attended their first scheduled colposcopy appointment. Providing a phone number as contact information was linked to improved adherence to colposcopy (1.27 [1.01-1.59]), whereas longer travel time between the healthcare facility and the colposcopy clinic was associated with a decrease in colposcopy adherence (0.68 [0.49-0.94]). Having a Pap recently was positively associated with better compliance with both outcomes (1.36 [0.96-1.94] for receiving results; 1.59 [1.10-2.29] for colposcopy adherence). Conclusion: We identified multilevel factors associated with abnormal test follow-up in patients in Mexico City. Additional research is necessary to design and test components for a multilevel intervention to address these factors and enable successful implementation of the follow-up process for abnormal screens from screening to diagnosis and treatment. Citation Format: Leith León-Maldonado, Raul U. Hernández-Ramírez, Leticia Torres-Ibarra, Donna Spiegelman, Sangini S Sheth, Eduardo Lazcano-Ponce, José Damián Cadena-Fiscal, Jorge Salmerón. Factors Associated With Receiving Results and Attending Colposcopy in Patients With Positive HPV Screens in Mexico City [abstract]. In: Proceedings of the 11th Annual Symposium on Global Cancer Research; Closing the Research-to-Implementation Gap; 2023 Apr 4-6. Philadelphia (PA): AACR; Cancer Epidemiol B","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135727417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected Articles from This Issue 本期精选文章
Pub Date : 2023-05-01 DOI: 10.1158/1055-9965.epi-32-5-hi
Highlights| May 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (5): 583. https://doi.org/10.1158/1055-9965.EPI-32-5-HI Related Content A commentary has been published: Changes in Breast Cancer Risk and Risk Factor Profiles among U.S.-Born and Immigrant Asian American Women Residing in the San Francisco Bay Area A commentary has been published: Risk and Protective Factors for Cancer Mortality among United States Service Members and Veterans (2001–2018) A commentary has been published: Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors View more A commentary has been published: Rural, Large Town, and Urban Differences in Optimal Subspecialty Follow-up and Survivorship Care Plan Documentation among Childhood Cancer Survivors View less Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record May 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 May 2023; 32 (5): 583. https://doi.org/10.1158/1055-9965.EPI-32-5-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search This longitudinal study analyzed data from the Millennium Cohort Study (2001–2018) to examine risk and protective factors for cancer mortality among service members and veterans. Findings revealed that non-deployers were more likely to die from cancer compared with deployers who did not experience combat, consistent with the healthy deployer effect. The study by Sharifian and colleagues also found that enlisted personnel were more likely to die from lung cancer than officers. This research is timely given current mandates to examine whether military-related exposures affect cancer risk among service members and veterans, including President Biden's Cancer Moonshot Program and the newly enacted VA PACT Act. Using Surveillance, Epidemiology, and End Results (SEER) program data from 1976 to 2015, Ou and colleagues used multiple methods to address unexamined questions about risk factors for Human-papillomavirus (HPV) associated second malignant neoplasms (SMN) among adolescent and young adult (AYA). The authors found that the burden... You do not currently have access to this content.
亮点| 2023年5月1日本刊文章精选作者与文章信息在线ISSN: 1538-7755印刷ISSN: 1055-9965©2023美国癌症研究协会2023美国癌症研究协会癌症流行病学生物标志物Prev(2023) 32(5): 583。https://doi.org/10.1158/1055-9965.EPI-32-5-HI相关内容发表了一篇评论:居住在旧金山湾区的美国出生和移民亚裔美国妇女乳腺癌风险和风险因素概况的变化发表了一篇评论:美国服役人员和退伍军人癌症死亡率的风险和保护因素(2001-2018)发表了一篇评论:青少年和青年癌症幸存者发生hpv相关恶性肿瘤的危险因素和趋势农村,大城镇和城市在儿童癌症幸存者中最优亚专业随访和幸存者护理计划文档中的差异查看较少视图图标查看文章内容图表和表格视频音频补充数据同行评审共享图标共享Facebook Twitter LinkedIn电子邮件工具图标工具获得许可引用图标引用搜索网站文章版本图标版本记录版本2023年5月1日引用本期精选文章。癌症流行病学生物标志物20123年5月1日;32(5): 583。https://doi.org/10.1158/1055-9965.EPI-32-5-HI下载引用文件:Ris (Zotero)参考文献管理人员EasyBib Bookends Mendeley论文EndNote RefWorks BibTex工具栏搜索搜索下拉菜单工具栏搜索搜索输入搜索输入自动建议搜索高级搜索这项纵向研究分析了千禧年队列研究(2001-2018)的数据,以检查服务人员和退伍军人癌症死亡率的风险和保护因素。调查结果显示,与没有经历过战斗的部署人员相比,未部署人员更有可能死于癌症,这与健康部署人员效应相一致。沙里夫安及其同事的研究还发现,士兵比军官更容易死于肺癌。这项研究是及时的,因为目前的任务是研究与军事有关的暴露是否会影响服务人员和退伍军人的癌症风险,包括拜登总统的癌症登月计划和新颁布的VA PACT法案。利用1976年至2015年的监测、流行病学和最终结果(SEER)项目数据,Ou和同事使用多种方法来解决青少年和年轻人(AYA)中人类乳头瘤病毒(HPV)相关的第二恶性肿瘤(SMN)危险因素的未检查问题。作者发现……您目前没有访问此内容的权限。
{"title":"Selected Articles from This Issue","authors":"","doi":"10.1158/1055-9965.epi-32-5-hi","DOIUrl":"https://doi.org/10.1158/1055-9965.epi-32-5-hi","url":null,"abstract":"Highlights| May 01 2023 Selected Articles from This Issue Author & Article Information Online ISSN: 1538-7755 Print ISSN: 1055-9965 ©2023 American Association for Cancer Research2023American Association for Cancer Research Cancer Epidemiol Biomarkers Prev (2023) 32 (5): 583. https://doi.org/10.1158/1055-9965.EPI-32-5-HI Related Content A commentary has been published: Changes in Breast Cancer Risk and Risk Factor Profiles among U.S.-Born and Immigrant Asian American Women Residing in the San Francisco Bay Area A commentary has been published: Risk and Protective Factors for Cancer Mortality among United States Service Members and Veterans (2001–2018) A commentary has been published: Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors View more A commentary has been published: Rural, Large Town, and Urban Differences in Optimal Subspecialty Follow-up and Survivorship Care Plan Documentation among Childhood Cancer Survivors View less Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Article Versions Icon Versions Version of Record May 1 2023 Citation Selected Articles from This Issue. Cancer Epidemiol Biomarkers Prev 1 May 2023; 32 (5): 583. https://doi.org/10.1158/1055-9965.EPI-32-5-HI Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search This longitudinal study analyzed data from the Millennium Cohort Study (2001–2018) to examine risk and protective factors for cancer mortality among service members and veterans. Findings revealed that non-deployers were more likely to die from cancer compared with deployers who did not experience combat, consistent with the healthy deployer effect. The study by Sharifian and colleagues also found that enlisted personnel were more likely to die from lung cancer than officers. This research is timely given current mandates to examine whether military-related exposures affect cancer risk among service members and veterans, including President Biden's Cancer Moonshot Program and the newly enacted VA PACT Act. Using Surveillance, Epidemiology, and End Results (SEER) program data from 1976 to 2015, Ou and colleagues used multiple methods to address unexamined questions about risk factors for Human-papillomavirus (HPV) associated second malignant neoplasms (SMN) among adolescent and young adult (AYA). The authors found that the burden... You do not currently have access to this content.","PeriodicalId":9488,"journal":{"name":"Cancer Epidemiology, Biomarkers & Prevention","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136095624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cancer Epidemiology, Biomarkers & Prevention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1